Delayed Localized Hypersensitivity Reactions to the Moderna COVID-19 Vaccine :  A Case Series

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

In response to the coronavirus disease 2019 (COVID-19) pandemic, 2 mRNA vaccines (Pfizer-BioNTech and Moderna) received emergency use authorization from the US Food and Drug Administration in December 2020. Some patients in the US have developed delayed localized cutaneous vaccine reactions that have been dubbed "COVID arm."

Related collections

Author and article information

Journal

Title: JAMA Dermatology

Abbreviated Title: JAMA Dermatol

Publisher: American Medical Association (AMA)

ISSN (Print): 2168-6068

Publication date (Electronic): May 12 2021

Affiliations

[1 ]Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut

[2 ]Department of Pathology, Yale University School of Medicine, New Haven, Connecticut

Article

DOI: 10.1001/jamadermatol.2021.1214

PMC ID: 8117061

PubMed ID: 33978670

SO-VID: 7b90d85e-c1be-4de9-be06-f42ea25e9370

History

Data availability:

Comments

Comment on this article

scite_

Cited by 70

See all cited by

Delayed Localized Hypersensitivity Reactions to the Moderna COVID-19 Vaccine : A Case Series

Read this article at